Both in Biotechnology
Ocugen vs Kyverna Therapeutics
Over the past year OCGN returned −51.8% and KYTX returned −24.4%; their daily moves had a correlation of 0.30.
OCGN −51.8% KYTX −24.4%Growth of $1, one year, split-adjusted
| Metric | OCGN | KYTX |
|---|---|---|
| Price | $0.7803 | $5.67 |
| Market cap | $264.6M | $350.7M |
| Today | −4.10% | −5.03% |
| 1 month | −24.2% | −19.5% |
| 6 months | −60.8% | −42.9% |
| Year to date | −42.2% | −39.7% |
| 1 year | −53.3% | −21.9% |
| Revenue growth (YoY) | +8.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −1671.8% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $15.9M | $174.4M |
| Dividend yield | — | — |
| Volatility (60d) | 70.0% | 59.3% |
| Short % of float | 31.5% | 26.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).